Clinical Trial Update: Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update announcing ongoing Phase 1/Phase 2 study of the CAPTEM regimen (capecitabine plus temozolomide) for newly diagnosed glioblastoma, currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Capecitabine (capecitabine)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Northwell Health | Conditions: Glioblastoma Multiforme (GBM), Glioblastoma | Phase 1, Phase 2 | Status: RECRUITING